After the diagnosis of pycnodysostosis, the patient’s treatment was initiated with human growth hormone therapy (rhGH) at a dose of 35 mcg/kg/day, but she responded poorly to the treatment and his pseudotumor cerebri showed clinical improvement and did not progress during the course of growth hormone therapy. Here, GH1 is linked to pseudotumor cerebri.